Literature DB >> 18514978

Evaluation of the potential of synthetic peptides of 80 kDa human sperm antigen (80 kDaHSA) for the development of contraceptive vaccine for male.

Bharati Gangaram Khobarekar1, Vandana Vernekar, Vijaya Raghavan, Masaharu Kamada, Masahiko Maegawa, Atmaram Hari Bandivdekar.   

Abstract

80 kDaHSA has been demonstrated to be responsible for inducing immunoinfertility. Synthetic peptides NT, 1, 2 and 4 of 80 kDaHSA are immunogenic and immunobiologically mimic the native protein. Peptides 1 and NT being highly immunogenic their potential for contraceptive vaccine development was evaluated. Active immunization of male rabbits with peptide-1 and -NT induced reversible infertility in 100% and 60% of animals, respectively and subsequently active immunization of non-human primate model, male marmosets with peptide-1 induced reversible infertility in six out of seven high antibody titer animals. The present study suggests the potential of peptide-1 of 80 kDaHSA for the development of contraceptive vaccine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514978     DOI: 10.1016/j.vaccine.2008.04.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Antisperm contraceptive vaccines: where we are and where we are going?

Authors:  Rajesh K Naz
Journal:  Am J Reprod Immunol       Date:  2011-04-11       Impact factor: 3.886

Review 2.  Milestones in contraceptive vaccines development and hurdles in their application.

Authors:  Satish Kumar Gupta; Abhinav Shrestha; Vidisha Minhas
Journal:  Hum Vaccin Immunother       Date:  2013-11-21       Impact factor: 3.452

Review 3.  Immunocontraceptives: new approaches to fertility control.

Authors:  Kiranjeet Kaur; Vijay Prabha
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

Review 4.  Development of antifertility vaccine using sperm specific proteins.

Authors:  A H Bandivdekar
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.